Boo Kuang Loon News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Boo kuang loon. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Boo Kuang Loon Today - Breaking & Trending Today

Malaysian firm aims to offer Chinese Covid-19 vaccine private sector by September


07 Jul 2021 / 13:21 H.
Bernama
KUALA LUMPUR: Malaysian firm Yong Tai Bhd, which has partnered China-based Shenzhen Kangtai Biological Products Co. Ltd. (SZKT) to supply Chinese-produced Covid-19 vaccine in Malaysia, is targeting to offer its vaccines to private sector by September or October.
Yong Tai s chief executive officer Boo Kuang Loon said the group, which has an agreement with SZKT to supply 10 million doses per year with an additional option of 10 million if required, has commenced its trial vaccination.
“We are currently conducting the Phase III Clinical Trial in Malaysia and have made an application to the National Pharmaceutical Regulatory Agency for approval to use the vaccines here. If everything goes smooth, we aim to obtain the approval by September or October,“ he told Xinhua in a recent written interview. ....

Kuala Lumpur , Yong Tai , Yong Tai Bhd , Solution Group , Myeg Services , Anhui Zhifei Longcom Biopharmaceutical Co , Shenzhen Kangtai Biological Products Co , National Pharmaceutical Regulatory Agency , Chinese Academy Of Sciences , China Based Shenzhen Kangtai Biological Products , Boo Kuang Loon , Anhui Zhifei Longcom Biopharmaceutical , Chinese Academy , குவாலா லம்பூர் , யோங் தை , யோங் தை ப்ட் , தீர்வு குழு , ஷென்சென் காங்க்டை உயிரியல் ப்ராடக்ட்ஸ் இணை , சீன கலைக்கழகம் ஆஃப் அறிவியல் , பூ குவாங் லூன் , சீன கலைக்கழகம் ,

Roundup: Malaysian firm aims to offer Chinese COVID-19 vaccine to private sector by September - World News


2021-07-07 04:05:31 GMT2021-07-07 12:05:31(Beijing Time) Xinhua English
KUALA LUMPUR, July 7 (Xinhua) Malaysian firm Yong Tai Bhd, which has partnered China-based Shenzhen Kangtai Biological Products Co. Ltd. (SZKT) to supply Chinese-produced COVID-19 vaccine in Malaysia, is targeting to offer its vaccines to private sector by September or October.
Yong Tai s chief executive officer Boo Kuang Loon said the group, which has an agreement with SZKT to supply 10 million doses per year with an additional option of 10 million if required, has commenced its trial vaccination.
We are currently conducting the Phase III Clinical Trial in Malaysia and have made an application to the National Pharmaceutical Regulatory Agency for approval to use the vaccines here. If everything goes smooth, we aim to obtain the approval by September or October, he told Xinhua in a recent written interview. ....

Kuala Lumpur , Yong Tai , Yong Tai Bhd , Solution Group , Myeg Services , Anhui Zhifei Longcom Biopharmaceutical Co , Shenzhen Kangtai Biological Products Co , National Pharmaceutical Regulatory Agency , Chinese Academy Of Sciences , China Based Shenzhen Kangtai Biological Products , Boo Kuang Loon , Anhui Zhifei Longcom Biopharmaceutical , Chinese Academy , குவாலா லம்பூர் , யோங் தை , யோங் தை ப்ட் , தீர்வு குழு , ஷென்சென் காங்க்டை உயிரியல் ப்ராடக்ட்ஸ் இணை , சீன கலைக்கழகம் ஆஃப் அறிவியல் , பூ குவாங் லூன் , சீன கலைக்கழகம் ,